Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 11Terminated 5Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Lymphoma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Leukemia 4Recurrence 3Multiple Myeloma 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Burkitt Lymphoma 3Neoplasms, Plasma Cell 2Myelodysplastic Syndromes 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Non-Hodgkin 2Lymphohistiocytosis, Hemophagocytic 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Lymphocytic, Chronic, B-Cell 2Immunoblastic Lymphadenopathy 2Hodgkin Disease 2Epstein-Barr Virus Infections 2Dendritic Cell Sarcoma, Interdigitating 2Unspecified Childhood Solid Tumor, Protocol Specific 1Sezary Syndrome 1Sarcoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Pneumonia, Pneumocystis 1Pneumonia 1Neuroma 1

Interventions

Cytarabine 5Peripheral Blood Stem Cell Transplantation 4Cyclophosphamide 4Busulfan 4Antilymphocyte Serum 4fludarabine phosphate 3Polymerase Chain Reaction 3Mycophenolic Acid 3Daunorubicin 3Cyclosporine 3Radiotherapy 2Gene Expression Profiling 2Filgrastim 2DNA Methylation 2sargramostim 1midostaurin 1laromustine 1eltrombopag 1dexamethasone acetate 1aldesleukin 1Therapeutics 1Tacrolimus 1Reverse Transcriptase Polymerase Chain Reaction 1Psychiatric Rehabilitation 1Pharmacogenomic Testing 1Microarray Analysis 1Methylprednisolone 1Methotrexate 1Melphalan 1Ketamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Congenital Abnormalities × Methylprednisolone × Clear all
NCT00008307 2014-01-06

Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders

National Cancer Institute (NCI)

Phase 2 Unknown
52 enrolled
DermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Congenital Abnormalities, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Recurrence, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡